{"id":28444,"date":"2012-03-21T23:18:30","date_gmt":"2012-03-22T03:18:30","guid":{"rendered":"http:\/\/countingpips.com\/fx\/?p=28444"},"modified":"2012-03-21T23:18:30","modified_gmt":"2012-03-22T03:18:30","slug":"amarin-corp-receives-u-s-patent-for-amer-101","status":"publish","type":"post","link":"https:\/\/www.investmacro.com\/fx\/2012\/03\/21\/amarin-corp-receives-u-s-patent-for-amer-101\/","title":{"rendered":"Amarin Corp. Receives U.S. Patent For AMER-101"},"content":{"rendered":"<p><div id=\"grabDiv1767162\"><object id=\"GrabPlayer1767162\" width=\"542\" height=\"304\" type=\"application\/x-shockwave-flash\" align=\"middle\" data=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v86978c24f7b75bc87a4af9f833c83e190410bafe&#038;tgt=grabnetworks\"><param name=\"quality\" value=\"high\"\/><param name=\"allowScriptAccess\" value=\"always\"\/><param name=\"allowFullScreen\" value=\"true\"\/><param name=\"menu\" value=\"false\"\/><param name=\"wmode\" value=\"transparent\"\/><param name=\"movie\" value=\"http:\/\/player.grabnetworks.com\/swf\/GrabOSMFPlayer.swf?id=1767162&#038;content=v86978c24f7b75bc87a4af9f833c83e190410bafe&#038;tgt=grabnetworks\"\/><\/object><\/p>\n<div id=\"overlay-adzone\" style=\"overflow:hidden; position:relative\"><\/div>\n<\/div>\n<p>Amarin Corp. (NASDAQ:AMRN) announced Tuesday that it was granted a key U.S. patent for its heart-drug candidate AMER-101, a treatment for high triglyceride levels.The product is currently waiting for approval by the FDA and should have a decision by late July.Share of the company were up 6% in midday trading.Amarin (NASDAQ:AMRN) has potential upside of 98.9% based on a current price of $11.23 and an average consensus analyst price target of $22.33.<\/p>\n<p><img src='http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/03\/21\/1_j2h7zve1_thumb.jpg' \/><\/p>\n<p><!--post_img[http:\/\/cache.thenewsroom.com\/financial_news_network\/2012\/03\/21\/1_j2h7zve1_preview.jpg]--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Amarin Corp. (NASDAQ:AMRN) announced Tuesday that it was granted a key U.S. patent for its heart-drug candidate AMER-101, a treatment for high triglyceride levels.The product is currently waiting for approval by the FDA and should have a decision by late July.Share of the company were up 6% in midday trading.Amarin (NASDAQ:AMRN) has potential upside of &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.investmacro.com\/fx\/2012\/03\/21\/amarin-corp-receives-u-s-patent-for-amer-101\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Amarin Corp. Receives U.S. Patent For AMER-101&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-28444","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/28444","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/comments?post=28444"}],"version-history":[{"count":0,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/posts\/28444\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/media?parent=28444"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/categories?post=28444"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.investmacro.com\/fx\/wp-json\/wp\/v2\/tags?post=28444"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}